Skip to main content
Addgene

Lenti‐Cas9‐2A‐Blast
(Plasmid #73310)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 73310 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    lenti CRISPR pXPR_001
  • Backbone manufacturer
    Feng Zhang
  • Backbone size w/o insert (bp) 6990
  • Total vector size (bp) 11214
  • Modifications to backbone
    Cas9-2A‐Blasticidin vector was modified from lentiCRISPR pXPR_001 (Addgene 49535) by removing the gRNA expressing sequence through NdeI, EcoRI digest and blunt end ligation using large Klenow fragments (NEB) to ligate sticky ends. 2A-­puro was replaced with an amplified 2A-blasticidin sequence with NheI and MluI sites
  • Vector type
    Mammalian Expression, Lentiviral, CRISPR
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Cas9
  • Alt name
    S. pyogenes CRISPR-Cas9
  • Species
    Synthetic
  • Insert Size (bp)
    4224
  • Promoter EFS-NS
  • Tag / Fusion Protein
    • FLAG (N terminal on insert)

Cloning Information

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    lentiCRISPR pXPR_001 (Addgene 49535)
  • Articles Citing this Plasmid

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    Lenti‐Cas9‐2A‐Blast was a gift from Jason Moffat (Addgene plasmid # 73310 ; http://n2t.net/addgene:73310 ; RRID:Addgene_73310)
  • For your References section:

    High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, Mero P, Dirks P, Sidhu S, Roth FP, Rissland OS, Durocher D, Angers S, Moffat J. Cell. 2015 Dec 3;163(6):1515-26. doi: 10.1016/j.cell.2015.11.015. Epub 2015 Nov 25. 10.1016/j.cell.2015.11.015 PubMed 26627737